keyword
https://read.qxmd.com/read/38530748/htlv-in-sweden
#21
REVIEW
Jan Vesterbacka, Anna-Karin Svensson, Piotr Nowak
Sweden is a country with a low prevalence of human lymphotropic T-cell virus (HTLV) infection, estimated at < 0.005%, but the infection rate is notably higher in specific risk groups such as HTLV-2 among intravenous drug users (IVDU) and people originating from HTLV-1 highly endemic areas. Thus, in the most recent study from 2012, the prevalence of HTLV-2 among IVDU in Stockholm was 3.2%. However, much of the epidemiological data on HTLV in Sweden stems from studies conducted primarily between the 1990s and 2007, and the impact of migration to Sweden during the past 15 years has not been evaluated...
2024: AIDS Reviews
https://read.qxmd.com/read/38522611/prevalence-of-htlv-1-2-infection-in-pregnant-women-in-central-and-south-america-and-the-caribbean-a-systematic-review-and-meta%C3%A2-analysis
#22
JOURNAL ARTICLE
Juan-Pablo Sánchez-Núñez, Eva de-Miguel-Balsa, Vicente Soriano, Edurado Lorenzo-Garrido, Angel Giménez-Richarte, Silvia Otero-Rodriguez, Juan-Carlos Celis-Salinas, Carmen de-Mendoza, Martin Casapia-Morales, José Manuel Ramos-Rincón
BACKGROUND: HTLV-1 infection is endemic in many countries of Central and South America & Caribbean (CSA&C). Neither screening nor surveillance programs exist for HTLV-1/2 infection among pregnant women in this region. Neither in Western nations with large migrant flows from HTLV-1/2 endemic regions. METHODS: Systematic review and meta‑analysis of the prevalence of HTLV-1/2 infection among CSA&C pregnant women. We included studies searching EMBASE, PubMed/MEDLINE, Scopus, and Web-of-Science from inception to February 15th 2023...
March 22, 2024: International Journal of Infectious Diseases: IJID
https://read.qxmd.com/read/38520941/htlv-1-associated-myelopathy-tropical-spastic-paraparesis-ham-tsp-case-based-discussion-of-risk-factors-clinical-and-therapeutic-considerations
#23
REVIEW
Lea Saab, Daniel DiCapua, Adeel S Zubair
HTLV-1 is a retrovirus virus that infects CD4+ T cells. Most people with HTLV-1 infection remain asymptomatic but some may develop conditions such as HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) or adult T-cell leukemia/lymphoma. HAM/TSP is characterized by progressive spasticity and weakness of the lower extremities, as well as loss of bladder control and sensory disturbances. The risk of developing HAM/TSP is associated with the duration of infection and the proviral load. There is currently no cure for the disease but medications can help manage symptoms and slow the progression of the disease...
March 19, 2024: Journal of the Neurological Sciences
https://read.qxmd.com/read/38502701/vulnerability-to-apobec3g-linked-to-the-pathogenicity-of-deltaretroviruses
#24
JOURNAL ARTICLE
Takafumi Shichijo, Jun-Ichirou Yasunaga, Kei Sato, Kisato Nosaka, Kosuke Toyoda, Miho Watanabe, Wenyi Zhang, Yoshio Koyanagi, Edward L Murphy, Roberta L Bruhn, Ki-Ryang Koh, Hirofumi Akari, Terumasa Ikeda, Reuben S Harris, Patrick L Green, Masao Matsuoka
Human retroviruses are derived from simian ones through cross-species transmission. These retroviruses are associated with little pathogenicity in their natural hosts, but in humans, HIV causes AIDS, and human T-cell leukemia virus type 1 (HTLV-1) induces adult T-cell leukemia-lymphoma (ATL). We analyzed the proviral sequences of HTLV-1, HTLV-2, and simian T-cell leukemia virus type 1 (STLV-1) from Japanese macaques ( Macaca fuscata ) and found that APOBEC3G (A3G) frequently generates G-to-A mutations in the HTLV-1 provirus, whereas such mutations are rare in the HTLV-2 and STLV-1 proviruses...
March 26, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38496506/htlv-1-infected-t-cells-cause-bone-loss-via-small-extracellular-vesicles
#25
Nitin Kumar Pokhrel, Amanda Panfil, Haniya Habib, Sham Seeniraj, Ancy Joseph, Daniel Rauch, Linda Cox, Robert Sprung, Petra Erdmann Gilmore, Qiang Zhang, R Reid Townsend, Lianbo Yu, Ayse Selen Yilmaz, Rajeev Aurora, William Park, Lee Ratner, Katherine N Weilbaecher, Deborah J Veis
Adult T cell leukemia (ATL), caused by infection with human T cell leukemia virus type 1 (HTLV-1), is often complicated by hypercalcemia and osteolytic lesions. Therefore, we studied the communication between patient-derived ATL cells (ATL-PDX) and HTLV-1 immortalized CD4+ T cell lines (HTLV/T) with osteoclasts and their effects on bone mass in mice. Intratibial inoculation of some HTLV/T lead to a profound local decrease in bone mass similar to marrow-replacing ATL-PDX, despite the fact that few HTLV/T cells persisted in the bone...
March 4, 2024: bioRxiv
https://read.qxmd.com/read/38489672/inhibitory-effect-of-a-neddylation-blockade-on-htlv-1-infected-t-cells-via-modulation-of-nf-%C3%AE%C2%BAb-ap-1-and-akt-signaling
#26
JOURNAL ARTICLE
Chie Ishikawa, Naoki Mori
Adult T-cell leukemia (ATL), caused by HTLV-1, is the most lethal hematological malignancy. NEDD8-activating enzyme (NAE) is a component of the NEDD8 conjunction pathway that regulates cullin-RING ubiquitin ligase (CRL) activity. HTLV-1-infected T cells expressed higher levels of NAE catalytic subunit UBA3 than normal peripheral blood mononuclear cells. NAE1 knockdown inhibited proliferation of HTLV-1-infected T cells. The NAE1 inhibitor MLN4924 suppressed neddylation of cullin and inhibited the CRL-mediated turnover of tumor suppressor proteins...
March 15, 2024: Leukemia & Lymphoma
https://read.qxmd.com/read/38479891/evaluating-a-retro-inverso-type-inhibitor-of-htlv-1-protease-as-a-competitive-inhibitor
#27
JOURNAL ARTICLE
Chiyuki Awahara, Daiki Oku, Kazuya Kobayashi, Yasunao Hattori
The inhibition mode of a retro-inverso (RI) inhibitor containing a hydroxyethylamine dipeptide isostere against the human T-cell leukemia virus type-1 (HTLV-1) protease was examined. Enzymatic evaluation of the RI-modified inhibitor containing a D-allo-Ile residue revealed that HTLV-1 was competitively inhibited. IC50 values of the RI-modified inhibitor and pepstatin A, a standard inhibitor of aspartic proteases, were nearly equivalent.
2024: Chemical & Pharmaceutical Bulletin
https://read.qxmd.com/read/38476951/evaluating-the-diagnostic-accuracy-of-tpn17-and-tmpa-recombinant-proteins-in-syphilis-detection-a-phase-ii-study
#28
JOURNAL ARTICLE
Ângelo Antônio Oliveira Silva, Ayla Araújo Lima, Larissa Carvalho Medrado Vasconcelos, Rosângela Andrade Almeida, Natália Erdens Maron Freitas, Talita Andrade Oliva, Miralba Freire de Carvalho Ribeiro da Silva, Fabricio Klerynton Marchini, Nilson Ivo Tonin Zanchin, Isadora Cristina de Siqueira, Fred Luciano Neves Santos
Syphilis is a sexually transmitted infection (STI) caused by the spiral bacterium Treponema pallidum . Diagnosis is based on epidemiology, clinical and serology, but serodiagnosis is challenging because distinct clinical forms of the infection may influence serological performance. Several recombinant Treponema pallidum -proteins have already been tested for syphilis diagnosis and they are critical to achieve high accuracy in serological testing. A total of 647 samples were included in the study: 180 T. pallidum -positive samples, 191 T...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38475892/varied-presentations-of-primary-cutaneous-lymphoma-a-case-series-from-a-tertiary-care-center-in-south-india
#29
JOURNAL ARTICLE
Baby Shana, Betsy Ambooken, Sunitha Balakrishnan, Asokan Neelakandan, Kidangazhiyathmana Ajithkumar
BACKGROUND: Recent studies indicate an upsurge of primary cutaneous lymphoma (PCL) in the Indian population. Of late, we too have come across varied presentations of PCL in relatively younger individuals. Hence, we decided to study the clinical and immunohistological profile of patients with PCL in our department. METHODS: All cases diagnosed as PCL from October 2016 to October 2019 were included. Clinical details, complete blood count, peripheral smear, imaging, histopathology, and immunohistochemistry of skin specimens were analyzed...
March 12, 2024: Indian Journal of Cancer
https://read.qxmd.com/read/38471667/revealing-the-hidden-interplay-the-unexplored-relationship-between-fungi-and-viruses-beyond-hiv-sars-cov-2-and-influenza
#30
REVIEW
Théo Ghelfenstein-Ferreira, Alexandra Serris, Maud Salmona, Fanny Lanternier, Alexandre Alanio
The complex interaction between viruses and fungi has profound implications, especially given the significant impact of these microorganisms on human health. While well-known examples such as HIV, influenza, and SARS-CoV-2 are recognized as risk factors for invasive fungal diseases, the relationship between viruses and fungi remains largely underexplored outside of these cases. Fungi and viruses can engage in symbiotic or synergistic interactions. Remarkably, some viruses, known as mycoviruses, can directly infect fungi, may influencing their phenotype and potentially their virulence...
March 28, 2024: Medical Mycology
https://read.qxmd.com/read/38469644/a-case-of-human-t-lymphotropic-virus-1-htlv-1-associated-lichenoid-dermatitis
#31
JOURNAL ARTICLE
Khawar Hussain, Nada Khalil, James Carton, Rashpal Flora, Eduardo Calonje, Neil P Patel
No abstract text is available yet for this article.
March 12, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38452534/proteomic-analysis-of-adult-t-cell-leukemia-lymphoma-a-biomarker-identification-strategy-based-on-preparation-and-in-solution-digestion-methods-of-total-proteins
#32
JOURNAL ARTICLE
Haruka Sudo, Yasuhiro Tonoyama, Emi Ikebe, Hiroo Hasegawa, Hidekatsu Iha, Yo-Ichi Ishida
Adult T-cell leukemia/lymphoma (ATL), caused by human T-cell leukemia virus type-1 (HTLV-1) infection, is a malignant hematologic cancer that remains difficult to cure. We herein established a biomarker identification strategy based on the total cell proteomics of cultured ATL cells to search for novel ATL biomarkers. Four protocols with a combination of selected conditions based on lysis buffers and addition agents for total cell proteomics were used for a differential analysis between the ATL cell group (consisting of 11 cell lines), HTLV-1-infected cell group (consisting of 6 cell lines), and HTLV-1-negative cell group (consisting of 6 cell lines)...
February 12, 2024: Leukemia Research
https://read.qxmd.com/read/38442342/the-origin-of-the-four-major-focus-of-htlv-1-in-latin-america
#33
JOURNAL ARTICLE
Vicente Soriano, José Manuel Ramos
No abstract text is available yet for this article.
March 5, 2024: AIDS Reviews
https://read.qxmd.com/read/38440568/adult-t-cell-leukemia-lymphoma-atl-in-the-nasal-and-paranasal-cavity-four-cases-report
#34
JOURNAL ARTICLE
Hiromi Nagano, Hayato Matsumoto, Yumi Miyamoto, Koji Takumi, Masatoyo Nakajo, Masaru Yamashita
Adult T-cell leukemia/lymphoma (ATL) is a form of leukemia caused by the human T-cell leukemia virus type I (HTLV-1). Otolaryngologists often diagnose ATL based on cervical lymphadenopathy or Waldeyer ring lesions. However, there are few reports of ATL occurring in the nasal and paranasal cavity. Here, we report four such cases of ATL. Case 1: An 82-year-old man diagnosed with acute-type ATL with a tumor in the nasal cavity underwent 5 courses of THP-COP, but died after 36 months due to ATL. Case 2: A 62-year-old woman diagnosed with lymphoma-type ATL with a tumor in the frontal sinus was treated with 5 courses of VCAP-AMP-VECP, and has survived for more than 10 years...
February 2024: Indian Journal of Otolaryngology and Head and Neck Surgery
https://read.qxmd.com/read/38436833/comprehensive-insight-into-the-functional-roles-of-nk-and-nkt-cells-in-htlv-1-associated-diseases-and-asymptomatic-carriers
#35
REVIEW
Maryam Mahdifar, Reza Boostani, Graham P Taylor, Seyed Abdolrahim Rezaee, Houshang Rafatpanah
Human T cell leukemia virus type 1 (HTLV-1) is the first human oncogenic retrovirus to be discovered and causes two major diseases: a progressive neuro-inflammatory disease, termed HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP), and an aggressive malignancy of T lymphocytes known as adult T cell leukemia (ATL). Innate and acquired immune responses play pivotal roles in controlling the status of HTLV-1-infected cells and such, the outcome of HTLV-1 infection. Natural killer cells (NKCs) are the effector cells of the innate immune system and are involved in controlling viral infections and several types of cancers...
March 4, 2024: Molecular Neurobiology
https://read.qxmd.com/read/38430272/multicenter-randomized-double-blind-placebo-controlled-phase-3-study-of-mogamulizumab-with-open-label-extension-study-in-a-minimum-number-of-patients-with-human-t-cell-leukemia-virus-type-1-associated-myelopathy
#36
JOURNAL ARTICLE
Tomoo Sato, Masahiro Nagai, Osamu Watanabe, Tatsuro Misu, Norihiro Takenouchi, Ryuichi Ohkubo, Satoshi Ishihara, Yoshio Tsuboi, Masahisa Katsuno, Masanori Nakagawa, Takuya Matsushita, Yasuhiro Aso, Eiji Matsuura, Takashi Tokashiki, Akihiro Mukaino, Hiroaki Adachi, Kaoru Nakanishi, Yusuke Yamaguchi, Saaya Yamaguchi, Yoshihisa Yamano
Human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic neurodegenerative disease. This multicenter, randomized phase 3 study evaluated the efficacy and safety of 0.3 mg/kg intravenous mogamulizumab, a monoclonal antibody targeting-CC chemokine receptor 4, every 12 weeks in HAM/TSP patients. This study comprised a 24-week double-blind, placebo-controlled period, 24-week open-label period, and extension treatment period. The primary endpoint was the proportion of patients with a ≥ 1-grade improvement in the Osame motor disability score (OMDS)...
March 2, 2024: Journal of Neurology
https://read.qxmd.com/read/38427693/the-impact-of-htlv-1-expression-on-the-3d-structure-and-expression-of-host-chromatin
#37
JOURNAL ARTICLE
Hiroko Yaguchi, Anat Melamed, Saumya Ramanayake, Helen Kiik, Aviva Witkover, Charles R M Bangham
A typical HTLV-1-infected individual carries >104 different HTLV-1-infected T cell clones, each with a single-copy provirus integrated in a unique genomic site. We previously showed that the HTLV-1 provirus causes aberrant transcription in the flanking host genome and, by binding the chromatin architectural protein CTCF, forms abnormal chromatin loops with the host genome. However, it remained unknown whether these effects were exerted simply by the presence of the provirus or were induced by its transcription...
March 1, 2024: PLoS Pathogens
https://read.qxmd.com/read/38400025/purification-method-of-extracellular-vesicles-derived-from-human-t-cell-leukemia-virus-type-1-infected-cells-without-virions
#38
JOURNAL ARTICLE
Katsumi Kawano, Yuki Hashikura, Kunihiko Umekita
To mediate intercellular communication, cells produce extracellular vesicles (EVs). These EVs transport many biomolecules such as proteins, nucleic acids, and lipids between cells and regulate pathophysiological actions in the recipient cell. However, EVs and virus particles produced from virus-infected cells are of similar size and specific gravity; therefore, the separation and purification of these two particles is often controversial. When analyzing the physiological functions of EVs from virus-infected cells, the presence or absence of virus particle contamination must always be verified...
February 4, 2024: Viruses
https://read.qxmd.com/read/38340584/stem-cell-therapy-for-htlv-1-induced-adult-t-cell-leukemia-lymphoma-atll-a-comprehensive-review
#39
REVIEW
Amir Gholamzad, Niloofar Khakpour, Mehrdad Gholamzad, Mohammad Reza Roudaki Sarvandani, Elaheh Mohandesi Khosroshahi, Saba Asadi, Mohsen Rashidi, Mehrdad Hashemi
Adult T-cell leukemia/lymphoma (ATLL) is a rare and aggressive form of cancer associated with human T-cell lymphotropic virus type 1 (HTLV-1) infection. The emerging field of stem cell therapies for ATLL is discussed, highlighting the potential of hematopoietic stem cell transplantation (HSCT) and genetically modified stem cells. HSCT aims to eradicate malignant T-cells and restore a functional immune system through the infusion of healthy donor stem cells. Genetically modified stem cells show promise in enhancing their ability to target and eliminate ATLL cells...
January 26, 2024: Pathology, Research and Practice
https://read.qxmd.com/read/38327581/how-do-socioeconomic-determinants-of-health-affect-the-likelihood-of-living-with-htlv-1-globally-a-systematic-review-with-meta-analysis
#40
Nydile Ramesh, Beatrice Cockbain, Graham P Taylor, Carolina Rosadas
INTRODUCTION: Human T Lymphotropic Virus type 1 (HTLV-1) is a neglected retrovirus associated with many clinical disorders, most notably Adult T-cell Leukemia/Lymphoma and HTLV-1-Associated Myelopathy (HAM). Found in endemic clusters across the world, high prevalence has been reported in minoritized groups who suffer from health inequities. This study investigates the association between HTLV-1 prevalence and the following socioeconomic determinants of health: education, income, and employment, which are markers of health inequity...
2024: Frontiers in Public Health
keyword
keyword
27278
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.